Overview

Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the outcome of intracranial germinoma treated with chemotherapy plus reduced radiotherapy.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Bleomycin
Carboplatin
Cyclophosphamide
Etoposide
Etoposide phosphate
Criteria
Inclusion Criteria:

- Patients with pathologically proven intracranial germinoma

Exclusion Criteria:

- Elevated serum/cerebrospinal fluid alpha-feto protein

- Patients with organ dysfunction as follows (creatinine elevation, ejection fraction,
liver function test > CTCAE grade 2)